Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1988-03-08
1990-09-18
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514934, A61K 3156
Patent
active
049579100
ABSTRACT:
A method is provided for treating a viral infection in a subject by administering a surfactant and/or a steroid so as to produce a high concentration thereof in the systemic circulation. The method is particularly applicable to the treatment of HIV infections. The use of surfactants and/or steroids in the production of pharmaceutical compositions is described.
REFERENCES:
patent: 4100276 (1978-11-01), Von Daehne et al.
patent: 4681876 (1987-07-01), Marples et al.
Reimund, E. Envelope perturbation and AIDS, Lancet 1986; 2:1159.
Chemical Abstracts 93:210277s, (1980).
Brugh, M. Butylated hydroxytoluene protects chickens exposed to Newcast disease virus. Science 1977; 197:1291-92.
Neale, G., Lewis, B., Weaver, V., Panveliwalla, D. Serum bile acids in liver disease. Gut 1971; 12:145-152.
Cowen, A. E., Korman, M. G., Hoffmann, A. F., Thomas, P. J. Plasma disappearance of radioactivity after travenous injection of labelled bile acids in man. Gastroenterology 1975; 68:1567-1573.
Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, London 1970;227:680-685.
Towbin, H., Staehelin, T. and Gordon, J. Electrophoretic transfer of proteins from polyacrylamidde gels to nitrocellulose sheets: procedure and some applications. Proc. Nat. Acad. Sci., U.S. 1979; 76:4350-4354.
Dunn, S. D. Effects of modification of transfer buffer composition and the renaturation of proteins in gels on the recognition of proteins on Western blots by monoclonal antibodies. Analyt. Biochem. 1986; 157:144-153.
Gallo, R. C., Gallagher, R. E. and Russell, F. In: Clarkson, B., Marks, P. A., Till, J. E. Eds. Differention of normal and neoplastic hematopoietic cells. Cold Spring Harbor. Cold Spring Harbor Press 1978;5:671-694.
Rey, M. A., Spire, B., Dormont, D. et al., Characterization of th RNA dependent DNA polymerase of a new human lymphotropic retrovirus (lymphaddenopathy associated virsu). Biochem. Biophys. Res. Comm. 1984; 121:126-133.
Heaton, K. W. Bile Salts in: Wright, R. Albertl., Kemm., Karrans, Millward-Sadzer, G H, Eds. Liver, Biliary Disease, London, W. B. Saunders, 1979:223-254.
Atkinson Anthony
Lloyd Graham
Sutton Peter M.
Public Health Laboratory Service Board
Schenkman Leonard
LandOfFree
Method and composition for the treatment and prevention of viral does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and composition for the treatment and prevention of viral, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and composition for the treatment and prevention of viral will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1572759